Vape reform discussion
Presentation slides from an Office of Drug Control information session on recent vaping reforms and their potential impacts on the medicinal cannabis industry.
Download Vape reform discussion presentation
Session overview
This information session provided an overview of recent regulatory changes affecting nicotine and non-nicotine vape products and the potential implications for suppliers of other vape medicines and devices.
The presentation covered:
- recent vaping reforms and associated regulatory changes
- the potential impacts of the reforms on the medicinal cannabis industry
- considerations for suppliers of vape medicines and devices
- process changes that may be required to comply with the new regulatory requirements.
Background
Recent reforms to the regulation of nicotine and non-nicotine vaping products introduced new requirements for consumers, suppliers and health professionals. These changes may also affect suppliers of other vape medicines and devices, including those operating within the medicinal cannabis sector.
This information session was delivered to help industry participants understand the reforms and identify any changes required to their business processes to meet the new regulatory arrangements.
Topics
- vaping reforms
- nicotine vaping products
- non-nicotine vaping products
- medicinal cannabis industry
- regulatory requirements
- vape medicines and devices
- supplier obligations
- compliance and implementation.